• Gene Variant Increases Risk Of Kidney Disease In African-Americans


    National Institutes Of Health

    Monday, October 24, 2011

    African-Americans with two copies of the APOL1 gene have about a 4 percent lifetime risk of developing a form of kidney disease, according to scientists at the National Institutes of Health. The finding brings scientists closer to understanding why African-Americans are four times more likely to develop kidney failure than whites, as they reported in the Oct. 13 online edition of the Journal of the American Society of Nephrology.

    Researchers including Jeffrey Kopp, M.D., at the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases and Cheryl Winkler, Ph.D, of the National Cancer Institute have begun tracing the effects of having two variants of the APOL1 gene, which occurs in about 12 percent of African-Americans.

    Researchers earlier linked this gene to susceptibility for kidney disease. When a person has kidney disease, the kidneys are unable to fully remove waste products and extra water from the blood. The researchers studied a common kidney disease called focal segmental glomerulosclerosis (FSGS), which often progresses to end-stage kidney disease and the need for dialysis or a kidney transplant. The researchers studied FSGS patients who came to the NIH Clinical Center or other collaborating medical centers, and who provided blood samples for genetic studies.

    “These findings explain nearly all of the excess risk of non-diabetic kidney failure in African-Americans. African-Americans with no variant or one variant have about the same risk of end-stage kidney disease as their white counterparts,” Winkler said. “People with two APOL1 variants have greatly increased risk of particular kidney diseases — by 17- to 30-fold.”

    The researchers found that African-Americans with two copies of the APOL1 variants have about a 4 percent lifetime risk of developing FSGS. Those who develop kidney disease tend to do so at younger ages than other FSGS patients, with 70 percent diagnosed with FSGS between age 15 and 39, compared to 42 percent in that age group for people with one or no APOL1 variants.

    Possessing two APOL1 variants also raises the risk for African-Americans with HIV of developing HIV-associated nephropathy (HIVAN) — a type of kidney disease that develops in some people with human immunodeficiency virus — to 50 percent among those not getting anti-viral therapy. Anti-viral therapy appears fairly effective at preventing HIVAN.

    “The much higher risk of kidney disease in patients with HIV suggests that a second hit with a virus or other unknown factor is necessary for kidney injury in people who have two APOL1 variants,” Winkler said. This may be why most people with two APOL1 variants do not develop kidney disease.

    FSGS patients with two APOL1 variants respond as well to steroid treatments as their counterparts who don’t have the variants, making steroids a viable treatment option, the researchers found. Further, they found that kidney disease progresses more rapidly in patients with two APOL1 variants, and they hypothesize that aggressive therapy may be advisable.

    “In the future, knowing that you have these gene variants and are at increased risk of developing kidney disease may tell you when to start screening for the disease and how to choose therapy,” Kopp said. “However, more research is needed, including clinical trials that test whether early genetic testing in the African-American population makes a difference, whether screening tests for young adults with the variant copies detects kidney disease at an early stage, and whether early treatment affects long-term outcome.”

    This research builds on earlier advances in understanding the role of genetics in kidney disease. In 2008, Kopp, Winkler and other researchers found that variants in the MYH9 gene on chromosome 22 are linked to susceptibility to various forms of kidney disease.

    In 2010, working with researchers at Harvard Medical School, among others, Kopp and Winkler found some kidney disease risk is due to variants APOLI, a gene adjacent to MYH9. These variants appear to have evolved about 5,000 years ago in some regions of sub-Saharan Africa to protect against trypanosomal infection, also called African sleeping sickness, a degenerative and potentially fatal disease affecting tens of thousands of people in those regions. People from other continents do not have the APOL1 variants.

    Kidney Disease Risks Among African Americans
    African Americans are more at risk for kidney failure than any other race. More than 1 in 3 kidney failure patients living in the United States is African American. That is over 150,000 people!
    Gene Hastens Kidney Disease Progression In African-Americans
    A gene variant common in African-Americans predicts that people with that gene who also have chronic kidney disease (CKD) are twice as likely to progress to kidney failure as African-Americans without the high-risk gene and white people with CKD.
    Young Teens At Raised Risk Of Kidney Transplant Failure
    Teens who receive a kidney transplant may be at increased risk of transplant failure, and the risk is especially high among young black patients, a new study finds.
    Black Medicaid Recipients Less Likely To Get Living-Donor Kidney
    Black Americans on Medicaid are far less likely to receive a living-donor kidney transplant than patients with private health insurance, a new study finds.
    Race And Geography May Influence Late-Stage Kidney Care
    At the end of life, black kidney disease patients are more likely than white patients to continue intensive dialysis instead of choosing hospice care, according to a new study.
    Blacks With Kidney Disease Should Watch For Blood Pressure Shifts
    Large day-to-day blood pressure changes in blacks with kidney disease are associated with an increased risk of premature death, a new study suggests.
    Blacks Less Likely To Receive Kidney Transplant Early On, Study Finds
    Black people and those without private health insurance are less likely than others to receive a kidney transplant before their condition deteriorates to the point that they need dialysis, according to researchers from Johns Hopkins University School of Medicine, in Baltimore.
    Racial Disparities Still Exist For Kidney Recipients
    The reversal of a kidney allocation policy has improved black patients’ chances of receiving a new organ from a deceased donor, U.S. researchers say.
    Black Children Less Likely To Get Kidney Transplant Before Dialysis
    Minority children are less likely than white children to get a kidney transplant before their kidney disease gets so bad they need dialysis, U.S. researchers find.
    Black Kidney Donors More Likely To Be Related To Recipients
    A new study on living kidney donation finds that black donors are more likely to be related to their recipients than white donors are.
    Research Reveals Why Blacks More Prone To Kidney Failure
    Black Americans are more likely than whites to have a condition in which the kidneys spill protein into the urine, which may help explain why blacks are four times more likely than whites to develop kidney failure, a new study suggests.
    Younger Blacks Fare Worse On Dialysis, Study Finds
    Researchers found that black patients younger than 50 years old who receive the blood-filtering process actually fare worse than whites.
    African Americans Kidney Disease Fact Sheet
    African Americans are nearly four times more likely than Caucasians to develop kidney failure, which requires dialysis or a kidney transplant.
    Tracy Morgan Feels Great After Kidney Transplant – Dec 2010
    Tracy Morgan has confirmed he is “feeling great” after a kidney transplant back in December 2010 and was up and about just four days after the operation.